Metipranolol
![]() | |
Clinical data | |
---|---|
Trade names | Optipranolol |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a601078 |
ATC code | S01ED04 (WHO) C07BA68 (WHO) |
Identifiers | |
| |
CAS Number | 22664-55-7 |
PubChem (CID) | 31477 |
IUPHAR/BPS | 7239 |
DrugBank |
DB01214 ![]() |
ChemSpider |
29193 ![]() |
UNII |
X39AL81KEB ![]() |
KEGG |
D02374 ![]() |
ChEMBL |
CHEMBL1291 ![]() |
ECHA InfoCard | 100.041.031 |
Chemical and physical data | |
Formula | C17H27NO4 |
Molar mass | 309.401 g/mol |
3D model (Jmol) | Interactive image |
Chirality | Racemic mixture |
| |
| |
(verify) |
Metipranolol (OptiPranolol, Betanol, Disorat, Trimepranol) is a non-selective beta blocker used in eye drops to treat glaucoma. It is rapidly metabolized into desacetylmetipranolol.[1]
References
- ↑ Maffei Facino, R.; Bertuletti, R.; Carini, M.; Tofanetti, O. (1980). "In vitro metabolism of methypranolol by rat liver". Analytical Chemistry Symposia Series. 4 (6): 217–223.
This article is issued from Wikipedia - version of the 6/3/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.